EATG » Tuberculosis

Tuberculosis

New blood tests for TB could accelerate diagnosis and save the NHS England money

Rapid blood tests used by the National Health Service (NHS) in England are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 348 of the ‘Global Fund Observer.’ The newsletter includes articles…

UNAIDS calls for a fully funded Global Fund to Fight AIDS, Tuberculosis and Malaria

GENEVA, 14 January 2019—As the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) launches its sixth replenishment for its next three-year funding cycle, UNAIDS is urging donors to…

Global Fund announces US$14 billion target to step up the fight against AIDS, TB and malaria ahead of Lyon Conference in October 2019

PARIS, 11 January 2019 – The Global Fund today announced its fundraising target for the next three-year cycle, outlining how a minimum of US$14 billion will help save 16 million lives,…

Issue brief: Backing Civil Society to End the AIDS, Tuberculosis and Malaria Epidemics

January 9, 2019 -- Friends of the Global Fight is releasing an issue brief today, “Backing Civil Society to End the AIDS, Tuberculosis and Malaria Epidemics.” This issue brief highlights the pivotal…

Study sheds more light on delamanid role in treating MDR-TB

A phase 3 trial of delamanid, a newer oral drug for treating multidrug-resistant tuberculosis (MDR-TB), found no statistically significant reduction in time to sputum culture conversion when compared to placebo,…

Diabetes challenges TB control in Europe

More than 10% of patients with tuberculosis enrolled in a study in eight European countries also had diabetes, including more than 28% of TB patients in England, researchers reported. “Diabetes…

WHO updates its treatment guidelines for MDR/RR-TB

21 December 2018 | Geneva – Multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) threaten global progress towards the targets of the End TB Strategy set by the World Health Organization (WHO). In 2018, WHO…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 347 of the ‘Global Fund Observer.’ The newsletter includes articles…

TAGline Fall 2018

Bringing down the House on intellectual property and access As the Trump administration makes noise about  the high price of pharmaceuticals while doubling down on its commitment to “protect the…

1 2 3 49